InspireMD to raise $113.6M via private placement
- InspireMD (NASDAQ:NSPR) signed a securities purchase agreement with certain healthcare-focused institutional investors that have agreed to provide up to $113.6M in gross proceeds to InspireMD through a private placement that includes initial upfront funding of $42.2M.
- Marvin Slosman, CEO, “This infusion of capital allows us to advance our business towards achieving milestones, including obtaining potential regulatory approval and launching of CGuard in the U.S., initiating new regulatory pathways for advanced applications of our CGuard stent platform, and developing new products, while at the same time continuing to grow our business outside of the United States."